Trump Medicare rule delays fix for drug price negotiation loophole
WASHINGTON — The Trump administration is delaying a proposal to crack down on a loophole that allows drugmakers…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…